Sanofi has firmed up its position in the red-hot area of radiopharmaceuticals for cancer with the purchase of a €300 million ($325 million) stake in Orano Med, a subsidiary of French nuclear ...

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class ...

Detailed price information for Molecular Partners Ag ADR (MOLN-Q) from The Globe and Mail including charting and trades.

LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics (“Molecular Partners” or the ...

Orano's La Hague reprocessing facility (Image ... ASN said it was temporarily suspending most of its inspections in medical facilities carrying out nuclear activities to enable health professionals to ...

Indeed, select companies developing Pb-212-based assets — such as ArtBio, AdvanCell, Perspective Therapeutics and Orano Med — have developed their own Pb-212 generator production capabilities.

It has collaborative with Orano Med to develop CLR 12120 Series; and LegoChem Bio. Cellectar Biosciences, Inc. was founded in 2002 and is headquartered in Florham Park, New Jersey.

Niger’s military-led government completed the nationalization of SOMAIR, a major uranium mining venture previously operated ...

Africa No Filter study links negative perceptions to weak consumer interest abroad • Over 40% of Africa-related associations in US and UK were seen as negative • Positive narratives proved more ...

Niger’s government says it will nationalize the Somaïr uranium venture operated by French company Orano over allegations that it took a disproportionate share of the uranium produced at the ...

New 40-person office in Oak Ridge leads the continuing development of Orano's planned multibillion-dollar uranium enrichment ...